SCHEMBL6197316

SCHEMBL6197316

COc1cc([CH]O)cc(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ CYP1A1 P04798 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP1B1 Q16678 1/20 0.55
▸ HPGD P15428 2/20 0.55
▸ GAA P10253 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ HTR1A P08908 1/20 0.55
▸ HTR2C P28335 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ TUBB1 Q9H4B7 9/20 0.53
▸ TUBB4A P04350 7/20 0.53
▸ TUBB P07437 7/20 0.53
▸ TUBA3C P0DPH7 7/20 0.53
▸ TUBA1B P68363 7/20 0.53
▸ TUBA4A P68366 7/20 0.53
▸ TUBB4B P68371 7/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4608533 0.80 CYP1A1 (0.79) CYP1A1CYP1A2CYP1B1HPGDGAA
SCHEMBL8910406 0.80 CYP1A1 (0.59) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL4608535 0.80 CYP1A1 (0.79) CYP1A1CYP1A2CYP1B1HPGDGAA
SCHEMBL1706535 0.78 CYP1A1 (0.57) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL14198035 0.77 GAA (0.56) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL25345289 0.76 CYP1A1 (0.55) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL2622571 0.76 CYP1A1 (0.67) CYP1A1CYP1A2CYP1B1HPGDGAA
SCHEMBL6199091 0.76 CYP1A1 (0.55) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL5804282 0.76 CYP1A1 (0.55) CYP3A4MAPTCYP1A1CYP1A2CYP1B1
SCHEMBL96635 0.76 ALDH1A1 (0.59) CYP3A4MAPTCYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 — — EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 — — EP disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 — — EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 — — US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 — — EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 — — US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 — — US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 — — EP disclosed
Send feedback